Cellectar Biosciences, Inc. (CLRB)
3.23
+0.27
(+9.12%)
USD |
NASDAQ |
Mar 12, 16:00
3.26
+0.03
(+0.93%)
After-Hours: 04:06
Cellectar Biosciences Total Assets (Quarterly) : 14.98M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| EyePoint Plc | 364.00M |
| Ocugen, Inc. | 44.29M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.059M |
| Shareholders Equity (Quarterly) | 9.919M |
| Debt to Equity Ratio | 0.0413 |
| Current Ratio | 2.956 |
| Net Debt Paydown Yield | 0.16% |